EQRx

company

About

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

  • 251 - 500

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$1.20B
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2019
Number Of Employee
251 - 500
Operating Status
Active

EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines.

By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before.

The company was founded in 2019 and is based in Cambridge, Massachusetts, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$1.90B
EQRx has raised a total of $1.90B in funding over 2 rounds. Their latest funding was raised on Dec 17, 2021 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 17, 2021 Post-IPO Equity $1.20B 2 SB Life Science Detail
Jan 11, 2021 Series B $500M 1 Detail
Jan 12, 2020 Series A $200M 1 Detail

Investments

Number of Investments
Number of Lead Investments
1
0
EQRx has made 1 investments. Their most recent investment was on May 15, 2021, when Bit.Country Network raised $4M.
Date Company Name
Round Money Raised Industry Lead Investor
Seed $4M Blockchain

Investors

Number of Lead Investors
Number of Investors
1
3
EQRx is funded by 3 investors. SB Life Science and Verily are the most recent investors.
Investor Name Lead Investor Funding Round
SB Life Science Yes Post-IPO Equity
Verily Post-IPO Equity
ARCH Venture Partners Series B